Record heat has lifted air-conditioning demand while gas-market shocks have returned volatility to power prices. That creates a real risk of painful bills—but not a guaranteed, Europe-wide price ...

A reliable home internet connection has become essential for everyday life. Whether you're working remotely, streaming your favorite shows, attending online classes, gaming, or managing smart home ...

Silver is not cheap or expensive in the same way as an equity because it has no earnings stream, so trailing P/E, forward P/E, EPS estimates, and EPS growth do not exist for the metal itself. The ...

Samsung's 2027 story is about monitoring the cycle correctly. The next two years should tell investors whether HBM and AI memory have created a better earnings floor or simply pulled future demand ...

Base case first: Samsung's 2030 outlook improved dramatically once HBM and AI memory demand turned from promise into earnings, but the stock is now much more sensitive to cycle timing and execution ...

Samsung's downside case is more credible now than it looked a few months ago because the stock has already moved to the top of its 10-year range while labor and cycle risks are rising, not falling.

Recent 2026 Edge patches improved Chromium core, but these issues persist for some. Ready to fix? Follow these steps in order – most users see results in minutes! ⭐ ...

The base case for Sensex into 2027 is not a blow-off top or a collapse. It is a range-bound but directionally constructive path that holds only if 23.48x trailing P/E is supported by earnings, the ...

The bullish case for natural gas does not require hype. It requires evidence that balances are still tightening or that demand is proving stronger than the market assumed. A serious energy article ...

Struggling to stay focused while reading articles, emails, or e-books? Imagine stripping away ads, sidebars, and clutter for a pure, customizable reading paradise. That's the magic of Microsoft Edge ...

Lilly remains a platform company across obesity, diabetes, immunology, neuroscience, and oncology, and earnings growth stays unusually strong deep into the next decade. The company grows into a large ...

Eli Lilly's base case into 2027 remains constructive because fundamentals are still outrunning the macro backdrop, but the stock already embeds a lot of success. At $1,006.70 on May 14, 2026 and ...